Kulick Melanie B, von Kügelgen Ivar
Department of Pharmacology, University of Bonn, Reuterstrasse 2b, D-53113 Bonn, Germany.
J Pharmacol Exp Ther. 2002 Nov;303(2):520-6. doi: 10.1124/jpet.102.037960.
In the search for P2-receptors modulating the stimulation-evoked entry of calcium at processes of PC12 cells differentiated in the presence of nerve growth factor and neurotrophin-3, electrically evoked increases in free calcium were assessed by fura-2 microfluorimetry. Omission of calcium and addition of cadmium (100 microM) or the N-type calcium channel blocker omega-conotoxin GVIA (0.5 microM) abolished or markedly reduced the evoked responses. The P2Y-receptor agonists 2-methylthio adenosine 5'-diphosphate (2-methylthio-ADP), ADP, and adenosine 5'-O-(2-thiodiphosphate) (ADPbetaS) inhibited the electrically evoked entry of calcium without any changes in basal calcium concentrations. 2-Methylthio-ADP was the most potent agonist. Adenosine, P(1),P(4)-di(adenosine-5')-tetraphosphate (Ap4A), UDP, and UTP (30 microM each) had no effect. The effect of ADPbetaS (30 microM) was abolished by the P2-antagonists reactive blue 2 (3 microM), suramin (100 microM), 2-methylthio-AMP (10 microM), p-chloromercuriphenyl sulfonic acid (1 microM), and AR-C 69931MX [N(6)-(2-methylthioethyl)-2-(3,3,3-trifluoropropylthio)-beta,gamma-dichloromethylene adenosine 5'-triphosphate] (300 nM). In contrast, pyridoxalphosphate-6-azophenyl-2',4'-disulfonic acid (10 microM), the selective P2Y1-receptor antagonist MRS 2179 (N(6)-methyl-2'-deoxyadenosine 3',5'-bisphosphate; 10 microM), as well as the adenosine A(1)-receptor antagonist DPCPX (8-cyclopentyl-1,3-dipropylxanthine; 100 nM), caused no change. Pretreatment with pertussis toxin abolished the effect of ADPbetaS. Reverse transcriptase-polymerase chain reaction revealed the presence of mRNA for P2Y12-receptors in nondifferentiated and differentiated PC12 cells. The results indicate that processes of differentiated PC12 cells possess P2Y12-receptors coupling to pertussis toxin-sensitive G-proteins and mediating an inhibition of the stimulation-evoked entry of calcium through omega-conotoxin GVIA-sensitive calcium channels. This suggests a role of P2Y12-receptors in neuromodulation in addition to their involvement in platelet aggregation.
在寻找可调节在神经生长因子和神经营养素-3存在下分化的PC12细胞突起处刺激诱发的钙内流的P2受体的过程中,通过fura-2显微荧光测定法评估电诱发的游离钙增加情况。去除钙并添加镉(100微摩尔)或N型钙通道阻滞剂ω-芋螺毒素GVIA(0.5微摩尔)可消除或显著降低诱发反应。P2Y受体激动剂2-甲硫基腺苷5'-二磷酸(2-甲硫基-ADP)、ADP和腺苷5'-O-(2-硫代二磷酸)(ADPβS)抑制电诱发的钙内流,而基础钙浓度无任何变化。2-甲硫基-ADP是最有效的激动剂。腺苷、P(1),P(4)-二(腺苷-5')-四磷酸(Ap4A)、UDP和UTP(各30微摩尔)无作用。P2拮抗剂反应性蓝2(3微摩尔)、苏拉明(100微摩尔)、2-甲硫基-AMP(10微摩尔)、对氯汞苯磺酸(1微摩尔)和AR-C 69931MX [N(6)-(2-甲硫基乙基)-2-(3,3,3-三氟丙硫基)-β,γ-二氯亚甲基腺苷5'-三磷酸](300纳摩尔)可消除ADPβS(30微摩尔)的作用。相反,磷酸吡哆醛-6-偶氮苯-2',4'-二磺酸(10微摩尔)、选择性P2Y1受体拮抗剂MRS 2179(N(6)-甲基-2'-脱氧腺苷3',5'-双磷酸;10微摩尔)以及腺苷A(1)受体拮抗剂DPCPX(8-环戊基-1,3-二丙基黄嘌呤;100纳摩尔)无变化。百日咳毒素预处理可消除ADPβS的作用。逆转录聚合酶链反应显示未分化和分化的PC12细胞中存在P2Y12受体的mRNA。结果表明,分化的PC12细胞突起具有与百日咳毒素敏感的G蛋白偶联的P2Y12受体,并介导通过ω-芋螺毒素GVIA敏感的钙通道抑制刺激诱发的钙内流。这表明P2Y12受体除了参与血小板聚集外,在神经调节中也起作用。